Valion Bio press releases
The latest press releases from Valion Bio (NASDAQ: VBIO), gathered from its own newsroom and from the newswires that carry it. PPN World follows 1,400+ press release feeds and adds each Valion Bio release within minutes of publication.
- Listing
- NASDAQ: VBIO
- Latest release
- Oct 30, 2026
- On this page
- 16 newest releases
Latest Valion Bio press releases
- Valion Bio Advancing Entolimod into U.S. Government-Funded Therapeutic ...
(PR-inside.com) NIAID-RNCP elects to evaluate the efficacy of Entolimod on gastrointestinal acute radiation syndrome ("GI-ARS"), after the announcement of positive safety findings Fully funded study w…
- Valion Bio Announces Positive Safety Results From U.S. Government-Funded ...
(PR-inside.com) AFRRI study found no evidence of treatment-related toxicity following a single dose of Entolimod, supporting advancement toward a planned, fully funded therapeutic study evaluating sur…
- Valion Bio Receives Unsolicited Acquisition Interest in Velocity Bioworks; ...
(PR-inside.com) Unsolicited Interest Reinforces Velocity's Strategic Value as Valion Bio Evaluates Opportunities to Advance Entolimod SAN ANTONIO, TX / ACCESS Newswire / October 26, 2026 / Valion Bio,…
The first 3 are open to everyone. A free account shows the rest and emails you the next Valion Bio release the minute it is out.
PPN World is independent and not affiliated with Valion Bio. Headlines and short excerpts only; each release links to its source.
Questions
Where can I find Valion Bio press releases?+
How do I get an alert when Valion Bio publishes a press release?+
Is this Valion Bio's official newsroom?+
Know the minute Valion Bio publishes
Watch Valion Bio, its competitors and its sector in one live feed, with email alerts — on the free plan.